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Accepted 3 January 2016; Published online 11 January 2016AbstractBackground: Chronic conditions burden patients with illness and treatments. We know little about the disruption of life by the work of
dialysis in relation to the resources patients can mobilize, that is, their capacity, to deal with such demands. We sought to determine the
disruption of life by dialysis and its relation to patient capacity to cope.
Methods: We administered a survey to 137 patients on dialysis at an academic medical center. We captured disruption from illness and
treatment, and physical, mental, personal, social, financial, and environmental aspects of patient capacity using validated scales. Covariates
included number of prescriptions, hours spent on health care, existence of dependents, age, sex, and income level.
Results: On average, patients reported levels of capacity and disruption comparable to published levels. In multivariate regression
models, limited physical, financial, and mental capacity were significantly associated with greater disruption. Patients in the top quartile
of disruption had lower-than-expected physical, financial, and mental capacity.
Conclusions: Our sample generally had capacity comparable to other populations and may be able to meet the demands imposed by
treatment. Those with reduced physical, financial, and mental capacity reported higher disruption and represent a vulnerable group that may
benefit from innovations in minimally disruptive medicine.  2016 The Authors. Published by Elsevier Inc. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Chronic conditions, defined as lasting 12 months or
more and limiting self-care, independent living or require
ongoing medical intervention [1], require ongoing, typi-
cally lifelong treatment that is burdensome to patients. Es-
timates in 2013 indicated that 117 million, or
approximately half of adults in the United States, had
one or more chronic conditions [2], whereas 26% of
adults in the United States had multiple chronic condi-
tions, up from 21.8% in 2001 [3]. Certain populations of
patients with chronic conditions have a higher prevalence
of comorbidities, such as patients with chronic kidney dis-
ease, where the prevalence of comorbidities has been esti-
mated at 56e86%, increasing with the severity of the
disease [4,5].Conflict of interest: None.
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licenses/by-nc-nd/4.0/).Chronic conditions cause pain, fatigue, and other symp-
toms, as well as functional limitations, which contribute to
the burden of illness. Additionally, they place another
burden on patients, this one arising from treatment tasks
[6]. Treatment burden can be defined as treatment work,
delegated by health care systems to patients and its impact
on their functioning and well-being; there are growing
demands on patients to organize their own care and self-
manage to comply with complex regimens [7,8]. A recent
systematic review found that patients with chronic condi-
tions spent on average 86 minutes per day managing a sin-
gle condition and 35 additional minutes for recommended
exercise. Although not daily, patients report spending
104e151 minutes for each health care encounter, including
transportation, waiting, and receiving care [9]. Further
complicating chronic care is the disease-centered nature
of clinical practice guidelines and quality metrics. Guide-
lines often fail to consider comorbidities, treatment burden,
patient preferences, or patient context [10]; the conse-
quence of their additive, uncoordinated, and often contra-
dictory tasks is increased treatment burden [11].ess article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. Cumulative Complexity Model.
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 The Cumulative Complexity Model was published
in 2012 as a conceptual model to guide research,
innovation, and implementation of minimally
disruptive medicine (MDM). This is the first article
that seeks to provide prospective exploration of
model concepts. Specifically, this article explores
a population with a high workload, providing the
ability to explore domains of patient capacity to
enact that work. Additionally, because this patient
population must adhere to treatment for survival,
disruption presumably affects their ability to pur-
sue their life’s joys, which we have measured
through illness and treatment intrusiveness.
 Patients on dialysis report capacity and disruption
from illness and treatment that is comparable to
other populations on average. However, patients
most disrupted by their illness and treatment had
deficits in their physical, emotional, and financial
capacity.
 Chronic conditions and the burden of their treat-
ment can overwhelm patients’ lives. Clinical care
should seek to identify patients that may be over-
whelmed by their care and identify and address ca-
pacity issues that patients may have. Where
capacity issues cannot be addressed by the health
care system, treatment plans should be adapted.
This requires careful clinical conversations about
coping with treatment and patient capacity, of
which innovations in MDM can support.Treatment burden alone is not the only factor: Eton et al.
found that multiple contextual issues may exacerbate treat-
ment burden, such as challenges taking medications,
emotional problems with family and friends, role and activ-
ity limitations, financial challenges to afford and access
health care, and health care delivery inefficiencies [12].
All of these can be considered barriers to patients accessing
their available abilities and resources to meet treatment
needs.
Minimally disruptive medicine (MDM) accounts for
these factors and is an approach to care emphasizing the
‘‘fit’’ of health care to patients’ lives [8,13]. It is grounded
in the Cumulative Complexity Model (CuCoM, see Fig. 1),
a model of patient complexity that outlines how clinical and
social factors complicate care and outcomes [14]. In the
CuCoM, every patient has a set of demands and responsi-
bilities in his or her life, which constitute the patient’s
‘‘workload.’’ This workload includes a person’s health care
tasks, but also competing demands required for other life
roles as parents, spouses, friends, caregivers, workers, andcommunity members. In meeting these demands, patients
have a finite capacity, which can be described as the abili-
ties and resources they can mobilize to manage this work-
load [14]. In some ways, our theoretical understanding of
capacity comports with the Conservation of Resources The-
ory, which states that people have objective resources, con-
ditions, personal characteristics, and energies available;
they seek to conserve these resources as they interact with
their environment and loss of them may cause stress [15].
For example, to address high self-care demands, a patient
may use their high health literacy to quickly and effectively
make sense of complex self-care regimens and multiple
follow-up visits to several physicians and solve problems;
or may enroll a spouse on whom to delegate the tasks of
organizing medications; or partner with a well-
coordinated health care system able to support self-care.
For some patients, capacity is sufficient to meet the
demands of care and the demands of life. However, others
experience an imbalancedthat is, when workload exceeds
capacity. The CuCoM posits that this imbalance means that
patients may be unable to access and use health care and
perform self-care alongside the other demands in their lives
[14]. Such an imbalance, we call disruption, could manifest
in two ways: (1) patients prioritize life’s demands, disrupt-
ing treatment adherence and self-care, and therefore result-
ing in worsening clinical outcome markers or (2) patients
prioritize necessary clinical care and self-care at the cost
of disrupted lives, manifesting as intrusion to their ability
to carry out meaningful activities such as hobbies and rela-
tionships. Although some patients can afford the former
with few immediate consequences, those with life-
threatening conditions requiring close control (e.g., dial-
ysis, highly active antiretroviral therapy for HIV) have little
option but the latter, meaning both illness and treatment,
become intrusive on their lives.
Despite some work on understanding and measuring
burden of treatment [6,7,12,16e18], patient capacity
remains largely unexamined. Certain domains of patient
capacity have, in isolation, been shown to affect patient out-
comes and behaviors [19,20]. Fatigue and self-efficacy
have been shown to be associated to self-management
behaviors [19e22], pain with depression status and coping
ability [23], financial hardship, and social support with
quality of life and mortality [24e31]. Attending to such
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patient capacity in interventions was associated with
greater effectiveness in reducing 30-day hospital readmis-
sions [32].1.1. Dialysis, disruption, and patient capacity
These issues of workload-capacity imbalance, treatment
burden, and illness burden play out in a heightened fashion
for patients with end-stage renal disease (ESRD) on dial-
ysis, making them an ideal population in which to study
aspects of the CuCoM. These patients struggle with a
time-consuming workload of health care and life restric-
tions [33,34] to decrease risks of hospitalizations and com-
plications and increase long-term survival [35e37]. Even
as dialysis patients work to meet treatment demands, they
also face pain, discomfort, fatigue, nausea, insomnia, heart
problems, and decreased mobility due to ESRD or dialysis
itself [38e40]. These factors combine in such a way that
patients on dialysis are a population that may be character-
ized as a population with both high illness burden and high
treatment burden.
High treatment burden, combined with a low baseline
capacity owing to burden of illness, leaves patients on dial-
ysis vulnerable to disruption from workload-capacity
imbalance, particularly if other areas of their capacity are
reduced. As postulated in the CuCoM, this disruption
may lead to problems accessing and using health care and
enacting self-care. Thus, identifying patients with diffi-
culties in varying capacity domains could identify targets
for intervention and prove fruitful in ensuring patients’
ability to manage the demands of their health care and a
good health-related quality of life. Capacity challenges
for patients on dialysis include struggles personally,
emotionally, physically, socially, financially, and environ-
mentally. Psychosocially, some patients are resilient in
coping [41e43], whereas others struggle [44] and express
regret, loss, and sadness related to dialysis [40]. Functional
struggles and social isolation can cause both depression and
anxiety [39,40], and financial stressors are common due to
treatment cost and diminished wage-earning abilities
[40,45,46]. However, health care services can be organized
to mitigate environmental challenges (e.g., transportation
and parking facilities), and those with competent staff can
facilitate patient participation in decision making and
learning together to empower patients and help them cope
with their condition [47].
Our study aims to document a comprehensive picture of
patient capacity in a group of patients on dialysis, the asso-
ciations between individual domains of patient capacity,
whether specific domains of patient capacity are associated
with the disruptiveness of illness and treatments for pa-
tients’ lives, and to provide further empirical evidence in
support of the CuCoM. A key assumption in testing the Cu-
CoM for this study is that this patient population has a high
treatment workload to adapt for survival, relative to otherchronic disease populations in which treatment workload
may more variable (e.g., asthma, diabetes). As such, capac-
ity, or lack of, is assumed as the primary driver of imbal-
ance for these patients. Additionally, because of the high
degree of adherence required for self-care, disruption in this
population can be measured as disruption to patients’ lives.2. Methods
2.1. Participants
We identified and invited all English-speaking patients
18 years or older presenting for hemodialysis or a home
dialysis checkup to either of two dialysis units in a large
multisite practice in the same Midwestern city in the United
States.
2.2. Instrument development, stakeholder input, and
pilot testing
We designed the survey instrument based on the CuCoM
and MDM. We identified key concepts of morbidity-related
and health careerelated life disruption and domains of pa-
tient capacity a priori through consultation with experts in
MDM and CuCoM. To identify measures, we then cross-
referenced those concepts with literature searches on
patient-centered experience and outcomes in dialysis; treat-
ment demands for dialysis patients; and health-related and
sociodemographic covariates (see measures in the
following).
After drafting the instrument, we sought input from a pa-
tient advisory group which meets regularly to consult with
researchers [48]. All patient advisors (n 5 15) took
10e15 minutes to complete the questionnaire on their
own. Primary concerns brought forth by the advisory group
(e.g., the length of the instrument; sensitivity of financial
capacity and income questions) were then explored during
cognitive interviewing (n 5 5) but did not require further
modification to the instrument [49]. The cognitive inter-
viewing procedure [49] included asking the patients to fill
the survey aloud and included follow-up questions at the
end of administration. Data from the surveys completed
by patient advisors were excluded from this analysis. We
also sought input from practicing clinicians (three nephrol-
ogists and two lead dialysis nurses) and a trained survey
methodologist, who is expert in the field (TJB); all re-
viewed the survey instrument, finding it highly relevant to
the patient population.
2.3. Survey administration
Following development, the lead author and eight
trained research assistants approached all patients visiting
the two dialysis centers during a 2-month period occurring
from late January to early April 2014. The lead nurse at
each site provided the research assistants a patient census
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ment dates. At the beginning of the day, the research assis-
tants would identify all patients receiving dialysis that day
from the list and seek to approach the next patient on the
list, completing as many surveys as possible during each
day as time allowed. They would confirm with the lead
nurse on staff for the day that no new patients had been
added, at which point they would be added to the master
list. All patients were approached onsite while they
received dialysis or waited for appointments. Patients were
not approached if their dialysis procedure was being started
or monitored actively by nursing staff, to ensure minimal
burden to both patients and staff. Research assistants main-
tained from the master list the patients that had been ap-
proached, and whether they had completed the survey,
wished to be approached again at a later time, or wished
to decline participation. The research assistants adminis-
tered the article-based surveys by oral interview; two pa-
tients asked to take the survey home and returned it at
their next appointment. Research assistants were members
of the Clinical Research Coordinator program at the clin-
ical site; all underwent human subjects protection training
and a 4-hour training on the project, survey administration,
and privacy protection and oral consent procedures. The
Mayo Clinic institutional review board approved the study
procedures; all patients provided oral consent at the time of
the survey.
2.4. Measures
2.4.1. Dependent variable
The dependent variable of interest was disruption due to
illness and treatment, as measured by an adapted Illness
Intrusiveness Scale, which has been validated in ESRD pa-
tients [50,51]. We chose to measure disruption as intrusive-
ness on life, rather than disruption of patient’s health care
and self-care tasks, because of the high level of adherence
required for this specific population. The adapted version
used here asks: ‘‘How much does your illness and/or its
treatments interfere with.’’ and includes 13 items such
as ‘‘your feeling of being healthy’’ and ‘‘your relationship
with your spouse or domestic partner,’’ with response op-
tions ranging from 0 to 7 and ‘‘not applicable’’ [52]. Not
applicable answers were coded as missing. Items were
summed for the scale (range: 0e91), with higher scores
indicating more intrusiveness.
2.4.2. Key independent variable
Patient capacity included eight validated measures of six
domains, and one scale from a Supplemental Item Set/
Appendix A at www.jclinepi.com, selected as described
previously. Personal capacity was measured using two
scales. First, resilience was measured by the Con-
noreDavidson Resilience Scale 2 (CD-RISC-2) [53], previ-
ously adapted from an original 25-item version measuring
‘‘bounce-back’’ ability. Second, self-efficacy was measuredusing the Stanford Patient Education Center’s Chronic Dis-
ease Self-efficacy, Manage Disease in General Scale [52].
Physical capacity was measured with the Pain Interference
and Fatigue PROMIS Short Form 4a scales [54]. Mental ca-
pacity was measured using the Emotional well-being scale
from the SF-36, version 1 [55]. We assessed social capacity
using the Instrumental Support PROMIS Short Form 4a
scale [54]. Financial capacity was measured using the In-
Charge Financial Distress/Financial Well-Being Scale
[56]. Environmental capacity was measured in two ways.
First, for home and neighborhood environmental capacity,
we used the Physical Activity Neighborhood Environment
Survey core scale, which includes items such as ‘‘It is
within a 10 to 15 minute walk to a transit stop (such as
bus, train, trolley, or tram) from my home’’ [57]. For health
care environmental capacity, we used modified versions of
four questions from the CAHPS Patient Health Care Home
Survey Supplemental Item Set/Appendix A at www.
jclinepi.com. These items were particularly aimed at under-
standing if the health care system was contributing to
patient capacity with well-coordinated and supportive
health care by asking questions such as ‘‘Thinking about
your health care in the last 12 months: Did anyone in your
primary care provider’s office ask you if there are things
that make it hard for you to take care of your health?’’ [58].
2.4.3. Workload
To assess workload of treatment and life demands, we
included single-item questions. To assess life workload,
we asked six questions such as ‘‘How many people would
you say rely or depend on you for something?’’ For treat-
ment workload, we asked two questions: ‘‘In a normal
week, how much time do you spend [in hours] managing
your health conditions?’’ and ‘‘How many different medi-
cations do you take daily on a regular basis?’’ Although
ongoing work seeks to measure treatment workload and
related concepts [6,7,12,59], at the time this survey was
developed, such instruments did not exist. Therefore, these
questions were not from previously validated instruments.
For all eight questions, patients were allowed to write in
the exact number and questions were treated as stand alone.
2.4.4. Covariates
General health was assessed with questions from the
SF-36 version 1, such as ‘‘In general, would you say your
health is’’: with responses ranging on a five-point scale
from excellent to poor [55]. Additional covariates collected
were age, gender, time on dialysis in years, marital status,
employment status, household income in dollars (five cate-
gories ranging from less than 20,000 to more than 75,000),
and one-way distance from the dialysis center in miles.
2.5. Analyses
All analyses were conducted in SAS, version 9.4
(NC, USA). In the descriptive statistics, we sought to
Table 1. Patient descriptive statistics
Characteristic % or Mean (SD) Missing
Female % 36.0 1
Marital status % 1
Married 51.8
Divorced 14.4
Widowed 11.5
Separated 2.9
Never been married 15.8
Unmarried couple 3.6
Age: mean (SD) 60.3 (15.7) 0
Time on dialysis in months: mean (SD) 32.8 (38.7) 12
Self-reported general health % 1
Excellent 5.0
Very good 14.4
Good 34.5
Fair 34.5
Poor 11.5
Employment % 10
Employed for wages 17.6
Self-employed 4.6
Out of work for O1 yr 2.3
Out of work for !1 yr 2.3
A homemaker 2.3
A student 0
Retired 42.3
Unable to work 28.5
Annual household income % 18
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comparators in chronic disease existed, the mean is
compared to a chronic disease population mean from previ-
ous literature (intrusiveness, self-efficacy) [52,60e62] or in
the case it did not, to the general population mean
(emotional well-being, financial well-being, resilience,
instrumental support, pain, and fatigue) [53,56,63,64].
Next, we analyzed Pearson bivariate correlations between
all capacity scales, three workload single-item questions
(those pertaining to the patient’s health care workload for
self or others), and intrusiveness. We then performed multi-
variate linear regression of intrusiveness on those capacity
domains that had been found significant at the bivariate
level, controlling for demographic characteristics of age,
sex, and income, and the workload factors directly related
to the patient’s health care workload (number of prescrip-
tions daily and hours spent managing health conditions
weekly). For capacity domains found statistically signifi-
cant in our multivariate linear regression model, we then
compared the mean for each domain in the uppermost vs.
lowermost observed quartiles of intrusiveness to assess
the relationship of capacity in these domains in patients
experiencing high disruption vs. low disruption. Pairwise
deletion was used in the case of missing data.Less than $20,000 36.9
$20,000e$34,999 23.0
$35,000e$49,999 15.6
$50,000e$74,999 12.3
More than $75,000 12.3
One-way distance from dialysis center 3
Less than 5 miles 28.5
6e15 miles 24.8
16e25 miles 16.1
26e50 miles 11.0
More than 50 miles 19.73. Results
Of all potential participants approached, 137 (70%)
agreed to participate (Table 1). Most patients were male,
married, and retired or unable to continue to work because
of their condition and treatment. Patients were on average
61 years of age and had been on dialysis for approximately
3 years.
Mean scores for each scale of capacity are reported in
Table 2, whereas Fig. 2 compares the mean capacity scores
of this cohort to previously collected samples. Cronbach
alpha reliability was generally very good across domains.
On average, patients reported capacity scores that were
comparable to previous capacity domains, where compari-
son population data were available.
Bivariate correlations are summarized in Table 3. Self-
efficacy and resilience had a weak, statistically significant,
negative correlation with intrusiveness. Pain, fatigue,
emotional well-being, and financial well-being had moder-
ate, statistically significant, positive correlations with intru-
siveness. Robust correlates among independent variables
included self-efficacy, resilience, emotional well-being,
pain, fatigue, and financial well-being (all significantly
related to each other with the exception of resilience and
financial well-being). Instrumental support and home and
health care environment were not significantly related to
intrusiveness or other independent variables.
Multivariate linear regression summarized in Table 4
illustrates that after adjusting for other factors, the capacity
variables with significant associations with intrusiveness,listed from strongest to weakest association (based on stan-
dardized coefficients), were as follows: fatigue, emotional
well-being, financial well-being, and pain. Among covari-
ates, only self-reported number of prescription medications
and sex were significantly associated with intrusiveness.
Missing income values accounts for many of the missing
cases in the regression (n 5 18). We imputed income to
ensure those missing income did not differ greatly in their
capacity scores, intrusiveness, or in the relationship between
capacity and intrusiveness; in doing so, we found that most
estimates were very similar (intercept suggested slightly
lower intrusivenessd17.7 vs. 20.9, only age changed direc-
tion, and no variables changed in significance).
Table 5 summarizes the capacity domains according to
the upper and lower observed quartiles of disruption to
assess basic nonlinear association. In capacity domains
found significant in the multivariate linear regression
model, patients with the highest levels of disruption
reported mean scores above the comparison mean scores
for pain and fatigue, whereas their less-disrupted counter-
parts reported below average pain and fatigue. Similarly,
Table 2. Patient capacity descriptive statistics
Dependent variable Mean (SD) a Missing
Disruption Intrusiveness (range 0e91) 35.9 (20.9) 0.90 1
Capacity domains Subdomains: independent variables
Personal capacity Resilience (possible range 0e8) 6.3 (1.7) 0.71 1
Self-efficacy (possible range 1e10) 7.4 (2.0) 0.82 1
Physical capacity Pain (possible range 41.6e75.6) 53.6 (11.2) 0.95 5
Fatigue (possible range 33.7e75.8) 56.7 (11.8) 0.92 3
Emotional capacity Emotional well-being (possible range 0e100) 74.4 (20.3) 0.84 1
Social capacity Instrumental support (possible range 29.3e63.3) 57.4 (7.6) 0.85 3
Environmental capacity Home environment (possible range 6e24) 13.8 (4.3) 0.61 2
Health care environment (possible range 4e16) 13.0 (3.3) 0.69 3a
Financial capacity Financial well-being (range 1e10) 5.8 (3.0) 0.95 2
a Twenty-two patients answered N/A to the items in this scale and were excluded from the correlation analysis.
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financial well-being below average to comparators, vs. their
less-disrupted counterparts who reported above average in
these areas. The study at hand sought to understand the
ways in which with the disruptiveness of illness from and
treatment are associated with specific domains of patient
capacity. Table 5 illustrates that despite mean capacity
scores comparable to other populations, patients most dis-
rupted by illness and treatment face capacity limitations
different from their counterparts that do not report disrup-
tion from illness and treatment.4. Discussion
4.1. Summary of findings
As judged by this newly developed survey tool, dialysis
patients in this sample reported comparable capacity in all
domains and disruption to their lives by treatment and
illness relative to comparison populations, in other chronic
disease populations (where available) or the general popu-
lation. Reduced physical, mental, and financial capacity
had the most robust significant correlations with patients’
reported disruptions in both univariate and multivariate
analyses. Furthermore, patients with the highest disruption
experienced deficits in each of these domains of capacity
compared to those reporting the lowest disruption. For
practice, this is important to consider: if a patient reports
relatively high disruption from their illness and treatment,
there may be a need to acknowledge their physical,
emotional, and financial capacity, to understand how these
issues play out in their ability to self-care, and to address
these capacity issues in addition to traditional medical
treatment alone. Because this study is the first to compre-
hensively assess patient capacity, these findings may pro-
vide a starting point for how and where to measure
patient capacity, and similar studies should be considered
in other chronic disease populations, including those with
presumed lower treatment workload. The CuCoM posits
that it is the balance of workload and capacity that impacts
patient’s abilities to access and use health care and enactself-care. By exploring the role of capacity in patient-
reported disruption in populations with varying levels of
workload provides guidance on where clinicians and health
professionals should target future intervention.
ESRD patients report capacity similar to other chronic dis-
ease and even general populations, despite facing severe
capacity limitations and disruptive illness and treatment.
There are a few plausible explanations for these findings, for
example, patients may have already adapted and normalized
to their circumstances. Clinicians who regularly treat outpa-
tient dialysis patients, however, may be unsurprised by this
finding. Indeed, some dialysis patients may be extremely ill
and frail, yet others are enjoying life and regularly socializing
despite the lengthy treatment, highlighting the heterogeneity
of experience of dialysis patients and the value in measuring
capacity rather than assuming that all have limitations. In addi-
tion, previously noted in the literature is the surprising resil-
ience in this population, often underscored by cognitive
styles that rely on positive reappraisal and optimism [43].
The correlation between emotional well-being and resilience
in this sample may further support this observation.
Yet despite higher than anticipated capacity on average,
capacity deficits were associated with disruptiveness, and
patients in the quartile most disrupted by their illness and
treatment showed severe limitations to their physical, mental,
and financial capacity. As an indication of workload-capacity
imbalance described in the CuCoM, left unchecked, high
levels of disruption may portend breakdowns in self-care,
poorer quality of life, and overall patient experience and the
capacity deficits associated with its presence deserve atten-
tion. Further work should be done to understand the relation-
ship betweendisruption, explored in this investigation, and the
two resulting pathways in themodel are as follows: (1) patient
access and use of health care, self-care and (2) health out-
comes. This will further connect elements of the CuCoM
framework not addressed in the present investigation.4.2. Implications for practice
MDM seeks to restore or work within the constraints of
the balance of patient’s workload and capacity, producing
Fig. 2. Cohort capacity means vs. general capacity means. *Higher pain and fatigue scores indicate lower physical capacity.
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duces outcomes aligned with their goals. Patient-reported
illness and treatment disruption as described in this article
may signal that clinical care is disrupting patients’ lives,
and that capacity constraints should be explored and
addressed. For example, clinicians, when meeting a patient
who reports high disruption from their illness and treatment
should consider potential constraints related to the patient’semotional, physical, and financial capacity. Where clini-
cians uncover physical or emotional problems, they may
be able to address these problems medically or with
referred services. Where they uncover financial constraints,
they may be unable to fix the financial struggles but will
need to adapt the treatment plan to ensure it does not over-
whelm the patient’s financial capacity. For example, clini-
cians and pharmacists could collaborate, in light of the
Table 3. Correlation matrix capacity variables and intrusiveness correlations
Domain Subdomain Intrusiveness Self-efficacy Resilience
Emotional
well-being Pain Fatigue Financial
Instrumental
support
Home
environment
Disruption Intrusiveness
Personal capacity Self-efficacy 0.411***
Resilience 0.243** 0.287***
Mental capacity Emotional
well-being
0.550*** 0.417*** 0.385***
Physical capacity Pain 0.517*** 0.527*** 0.175* 0.350***
Fatigue 0.612*** 0.421*** 0.257** 0.473*** 0.539***
Financial capacity Financial
well-being
0.505*** 0.404*** 0.131 0.421*** 0.386*** 0.348***
Social capacity Instrumental
support
0.014 0.066 0.137 0.132 0.111 0.046 0.128
Environmental
capacity
Home
environment
0.073 0.108 0.191* 0.057 0.026 0.023 0.031 0.008
Health care
environment
0.051 0.056 0.059 0.040 0.049 0.104 0.128 0.173 0.110
Missing data in Table 2.
*P ! 0.05, **P ! 0.01, ***P ! 0.001.
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cribe treatments as necessary such that the total treatment
plan does not exceed the patient’s financial capacity. The
CuCoM posits that could both create less burdensome care
and improve patient outcomes. To our knowledge, however,
MDM remains untested.4.3. Limitations and strengths
This study should not be interpretedwithout considering its
limitations. First, although the dialysis population was
selected because of its high rates of comorbidities seen at
the population level [4,5], caution must be taken when extrap-
olating its findings to other populations with multimorbidity.
Because of the nature of dialysis treatment, the perceived
illness and treatment burdens may fluctuate within a single
week, which could bias measurement and extrapolation.
Further study in this regard is warranted. Other sources of
measurement error include the possibility that selected scales
do not adequately tap into areas of patient capacity in dialysis
that have the greatest deficits. For example, instrumentalTable 4. Multivariate linear regression model of patient disruption: workload
Domain Variable
Intercept
Demographics Age
Sex
Income
Workload Weekly hours spent caring for health
Number of prescriptions daily
Personal capacity Self-efficacy
Resilience
Mental capacity Emotional well-being
Physical capacity Pain
Fatigue
Financial capacity Financial well-being
Missing data, n 5 28.support was selected as a measure of social capacity, whereas
loneliness could have been explored instead. Second, potential
bias in the sample should be considered; the setting in which
this study occurredwas a relatively socially homogenous pop-
ulation with good access to care at a single clinic in the Mid-
west. This might be responsible for certain patterns (e.g.,
higher than anticipated capacity across most domains) and
may have limited the observed associations (due to limited
variability) of environmental and social capacity domainswith
disruption. Findings may also differ in populations with
greater heterogeneity of race, incomedistribution, access, pro-
viders, or geography, suggesting limited generalizability
pending further research. Finally, this study was cross-
sectional, and therefore, we cannot establish causality or draw
longitudinal inferences. Therefore, further work is needed to
testwhether attention to patient capacitywould causally affect
disruption, and, in turn, whether this could result in better
health outcomes. Moreover, confounding relationships are
possible (unmeasured factors may be simultaneously causing
both high disruption and low capacity). An example of such
unmeasured factor could be the sudden illness of a familyand capacity variables
Estimate P-value
Standardized b
coefficient
20.9 0.17
0.01 0.89 0.01
6.62 0.01 0.15
1.86 0.07 0.13
0.07 0.20 0.08
0.66 0.03 0.15
0.67 0.43 0.06
0.08 0.91 0.01
0.25 !0.01 0.26
0.36 0.02 0.19
0.65 !0.001 0.38
1.64 !0.01 0.24
Table 5. Upper and lower quartiles of disruption across robust capacity correlates
Domain Subdomain
Upper quartile, mean
(95% CI)
Lower quartile, mean
(95% CI)
Physical capacity Pain 59.7 (55.8e63.6) 45.7 (43.0e48.3)
Fatigue 65.6 (62.8e68.4) 48.2 (44.9e51.6)
Mental capacity Emotional well-being 57.6 (50.3e64.9) 85.1 (80.2e90.0)
Financial capacity Financial well-being 3.9 (3.1e4.6) 7.7 (6.9e8.5)
Abbreviation: CI, confidence interval.
235K.R. Boehmer et al. / Journal of Clinical Epidemiology 74 (2016) 227e236member that disrupts the patient’s life and also causes an acute
drop in their personal capacity to enact their own care.
Despite these limitations, this study makes multiple contri-
butions to the current literature. First, this study used previ-
ously validated scales for the measurement of the capacity
domains and subjected the full survey instrument to rigorous
patient and clinician stakeholder input. Additionally, the
results painted thefirst comprehensive picture of patient capac-
ity as described by CuCoM in any population, and the flexi-
bility of the survey and its development process lends itself
to future research in other populationswith chronic conditions.
Finally, this study assessed in a clinical setting a key aspect of
care that is rarely examined by clinicians, and one that is
beyond what can be ascertained with secondary data sources.5. Conclusion
Patients on dialysis reported moderate disruption of their
illness and treatment, and levels of capacity comparable to
previous nondialysis populations. Physical, mental, and
financial capacity had the most robust associations with
patient-reported disruption, and patients with the highest
disruption reported noteworthy capacity deficits in these
three areas. Future health services research needs to be con-
ducted to uncover the extent to which clinical teams are
aware of these capacity problems, methods to routinely
assess patient capacity in a minimally burdensome manner,
and what associations exist between capacity deficits and
patient health outcomes. Furthermore, research should seek
to translate these findings by incorporating discussions of
patient capacity into regular clinical conversations and
testing new forms of care delivery to patients with multiple
chronic conditions such as MDM.Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.jclinepi.2016.01.006.References
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